Last reviewed · How we verify

Tramadol Once A Day

Labopharm Inc. · Phase 3 active Small molecule

Tramadol is a centrally acting opioid analgesic that works by binding to opioid receptors in the brain and spinal cord.

Tramadol is a centrally acting opioid analgesic that works by binding to opioid receptors in the brain and spinal cord. Used for Moderate to moderately severe pain, Severe pain.

At a glance

Generic nameTramadol Once A Day
SponsorLabopharm Inc.
Drug classOpioid analgesic
Targetmu-opioid receptor
ModalitySmall molecule
Therapeutic areaPain management
PhasePhase 3

Mechanism of action

This binding causes a decrease in the transmission of pain signals to the brain, resulting in pain relief. Tramadol also inhibits the reuptake of norepinephrine and serotonin, which can contribute to its analgesic effects.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: